Found 52 matching trials
Busulfan and Cyclophosphamide Followed By ALLO BMT NA This is a treatment guideline to allow routine clinical data to be collecte...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma PHASE1 Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Show More Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Learn More & Join Trial
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT PHASE3 To observe the effect of stem cell infusion on the development of acute gra...
Show More Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital
Learn More & Join Trial
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases PHASE2 RATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophospham...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury PHASE1 Study evaluates the safety and primary efficiency of systemic (i.v.) alloge...
Show More Location
N.V. Sklifosovsky Emergency Care Institute
Learn More & Join Trial
Transplacental Gradients and Transport in Intrauterine Growth Restricted (IUGR) Pregnancies Compared to Normal Pregnancies. NA The purpose of this study is to determine whether the transplacental gradie...
Show More Location
University of Colorado Denver Anschutz Medical Campus
Learn More & Join Trial
A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies PHASE1 This is an open-label, safety study of a single ProHema-CB product administ...
Show More Learn More & Join Trial
Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning PHASE1 The effects and safety of Human cord blood mononuclear cell for delayed enc...
Show More Location
Liaocheng city people's hospital
Learn More & Join Trial
Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders NA This study is designed to test the ability to achieve donor hematopoietic e...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies PHASE1 The goal of this clinical research study is to find the recommended safe do...
Show More Location
The University of Texas M. D. Anderson Cancer Center
Learn More & Join Trial